Benjamin Edwards’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.79M Buy
67,623
+6,021
+10% +$262K 0.03% 490
2026
Q2
$2.63M Buy
61,602
+3,493
+6% +$156K 0.02% 495
2026
Q1
$2.8M Buy
58,109
+31,528
+119% +$1.47M 0.03% 456
2025
Q4
$1.29M Sell
26,581
-22
-0.1% -$1.09K 0.01% 627
2025
Q3
$1.26M Sell
26,603
-1,558
-6% -$75.2K 0.01% 619
2025
Q2
$1.36M Buy
28,161
+8,329
+42% +$426K 0.02% 541
2025
Q1
$1.1M Buy
19,832
+3,092
+18% +$167K 0.02% 550
2024
Q4
$807K Sell
16,740
-453
-3% -$23K 0.01% 680
2024
Q3
$991K Buy
+17,193
New +$928K 0.01% 605

Other funds holding SNY

Benjamin Edwards's SNY Position: Q3 2026 in Review

Benjamin Edwards increased its Sanofi (SNY) stake by 9.8% in Q3 2026, buying an estimated $262K and bringing the position to 67,623 shares worth $2.79M. The position accounts for 0.03% of the portfolio, ranked #490.

Benjamin Edwards first reported a position in SNY in Q3 2024 and has held it in 9 quarters since. The position peaked at $2.8M in Q1 2026. 577 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Benjamin Edwards held 67,623 shares of Sanofi worth $2.79M as of Q3 2026.
  • Benjamin Edwards bought 6,021 Sanofi shares in Q3 2026, an estimated $262K.
  • Sanofi made up 0.03% of Benjamin Edwards's portfolio in Q3 2026, its #490 holding.
  • Benjamin Edwards first reported a position in Sanofi in Q3 2024 and has held it in 9 quarters since.
  • Benjamin Edwards's Sanofi position peaked at $2.8M in Q1 2026.
  • 577 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.